Research ArticleResearchWorkflow

Clinician override identified higher risk within low-HEART-score chest pain

Journal of the American College of Emergency Physicians open (PubMed)Sep 4, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In a large retrospective multicenter cohort of emergency patients with low HEART scores, admission despite the score identified a subgroup with a higher observed rate of 30-day major adverse cardiovascular events.

What NurseJet pulled from the source

Among 33,392 low-risk encounters, 2,101 patients were admitted despite HEART scores below 4. Thirty-day major adverse cardiovascular events occurred in 1.90% of admitted patients and 0.26% of discharged patients.

Why this matters for nurses

Emergency nurses combine structured risk tools with serial assessment and escalation. The findings support treating a low score as one input rather than a substitute for the complete clinical picture.

Bedside takeaway

A low HEART score should not replace serial assessment and escalation of persistent clinical concern.

Key takeaways

Clinician override occurred in 6.3% of low-HEART-score encounters.
After adjustment, admission despite a low score was associated with higher odds of a 30-day event (adjusted OR 5.16; 95% CI 3.40 to 7.82).
Adding clinician override improved discrimination beyond the baseline clinical model, but the observational design cannot establish why the difference occurred.

Practice implications

Follow the local chest-pain pathway, continue reassessment, and escalate concerning symptoms, troponin trends, electrocardiographic changes, or clinician concern even when the calculated HEART score is low.

Limitations & cautions

Abstract-only summary. This retrospective study used admission as a marker of clinician override, so residual confounding and selection bias may explain part of the association; it did not test an override intervention.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Journal of the American College of Emergency Physicians open (PubMed)

Journal of the American College of Emergency Physicians open (PubMed). Hospital Admission Despite Low-Risk History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) Scores and 30-Day Outcomes in Emergency Department Chest Pain.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42733440/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Family Medicine and Community Health (PubMed)Sep 22, 2026Systematic Review

A dose-response meta-analysis of prospective cohorts found that higher ultra-processed food intake was associated with higher risks of cardiovascular events, cancer, obesity or overweight, metabolic syndrome or diabetes, depression or anxiety, digestive disease, and all-cause mortality.

Med-Surg TelemetryAI summaryReview source

Systematic ReviewResearchPatient EducationAI summary · original source linked below

The review included 51 prospective cohort studies with 8,819,894 adults. Each additional 100 g/day of ultra-processed food was associated with higher risks of cardiovascular events, cancer, all-cause mortality, and metabolic syndrome or diabetes, but the authors rated the evidence as low or moderate.

Key takeaways

The pooled comparison associated higher ultra-processed food intake with a 24% higher hazard of cardiovascular events and an 18% higher hazard of all-cause mortality.
Diet exposure was measured with food-frequency questionnaires, 24-hour recalls, or dietary histories rather than a standardized intervention.
These prospective observational associations do not establish that ultra-processed food caused the reported outcomes.

Why this matters on shift

Nurses frequently reinforce nutrition plans during chronic-disease education and discharge teaching. This broad evidence synthesis supports discussing food-processing patterns as one part of individualized education while avoiding causal claims or rigid advice based on one dietary measure.

Bedside takeaway

Use processing patterns as one part of individualized nutrition teaching, and describe the evidence as associative rather than causal.

Nursing implications

When nutrition teaching is within the care plan, assess the patient's usual foods and access barriers, reinforce the dietitian or clinical team's recommendations, and use teach-back. Avoid presenting this observational review as proof that one food category caused an individual patient's disease.

Limitations & cautions

The evidence came from prospective cohorts rather than randomized dietary interventions, intake measurement varied, and residual confounding is possible. The authors rated the evidence as low or moderate, so the hazard ratios describe associations rather than causal effects.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Family Medicine and Community Health (PubMed). Ultra-processed food consumption and risk of multiple chronic diseases among 8,819,894 adults from 51 prospective cohorts: a dose-response meta-analysis.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of Neurology (PubMed)Sep 20, 2026Systematic Review

A systematic review characterized cancer-associated coagulopathy stroke as an underrecognized ischemic stroke mechanism linked to advanced cancer, early recurrence, and poor outcomes.

Emergency OncologyAI summaryReview source

Systematic ReviewResearchMedication SafetyWorkflowAI summary · original source linked below

The qualitative review included 82 studies. Cancer-associated coagulopathy stroke occurred predominantly within six months of cancer diagnosis, most often with advanced or metastatic adenocarcinoma; D-dimer was the biomarker most consistently associated with recurrence and mortality, and reported 30-day mortality ranged from 25% to 50%.

Key takeaways

Lung and pancreatic adenocarcinomas were the histologic subtypes most frequently associated with cancer-related coagulopathy stroke.
Multiple infarcts across more than two vascular territories were a characteristic imaging pattern described in the review.
Low-molecular-weight heparin and direct oral anticoagulants were commonly used for secondary prevention, but the review did not establish one optimal antithrombotic strategy.

Why this matters on shift

Neuro and oncology nurses may be first to recognize a new focal deficit or recurrent neurologic change in a patient with active cancer. The review highlights a high-risk stroke mechanism that requires rapid assessment while leaving treatment selection to individualized multidisciplinary evaluation.

Bedside takeaway

Escalate new neurologic deficits immediately and communicate the patient's cancer and antithrombotic context to the stroke team.

Nursing implications

Treat any new focal neurologic deficit as an emergency, document onset and progression precisely, and promptly communicate active or metastatic cancer, recent cancer diagnosis, coagulation results, and current antithrombotic therapy to the stroke team. Follow facility stroke and anticoagulation protocols and provider orders.

Limitations & cautions

The review synthesized heterogeneous studies qualitatively and did not report a pooled treatment comparison. Biomarkers other than D-dimer had limited specificity, and the abstract does not support choosing one anticoagulant or screening strategy.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of Neurology (PubMed). Stroke secondary to cancer-associated coagulopathy: a systematic review.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Journal of NeuroEngineering and Rehabilitation (PubMed)Sep 10, 2026Research Article

An assessor-blinded randomized trial found no significant advantage for a sensor-assisted soft robotic glove over supervised repetitive arm training during inpatient stroke rehabilitation.

EmergencyAI summaryReview source

Research ArticleResearchWorkflowAI summary · original source linked below

The trial randomized 61 adults with ischemic or hemorrhagic stroke and unilateral arm impairment; 58 completed the post-intervention assessment. Both groups improved after up to 15 sessions, but no statistically significant between-group differences were found in the primary or secondary outcomes.

Key takeaways

Participants received either robotic-glove training or supervised GRASP training for 30 to 45 minutes per session, up to five days weekly for three weeks.
A post-hoc subgroup signal for distal hand recovery favored the glove immediately after treatment but was not present at three months.
The trial stopped before reaching its planned sample size and was underpowered for the prespecified between-group difference.

Why this matters on shift

Rehabilitation nurses reinforce prescribed practice, monitor tolerance, and help patients carry therapy goals into daily activity. The result does not support assuming that a robotic device is superior to a structured, supervised exercise program.

Bedside takeaway

Do not assume a robotic glove is better than structured supervised practice; follow the individualized stroke-rehabilitation plan.

Nursing implications

Follow the individualized rehabilitation plan, help patients complete ordered repetitive upper-limb practice safely, and document fatigue, pain, skin issues, or barriers to participation. Present robotic devices as one possible therapy tool, not as proven superior treatment.

Limitations & cautions

The trial was underpowered after recruitment stopped for funding constraints. The exploratory subgroup finding was post hoc, involved 38 participants, and did not persist at three months; the device manufacturer was involved in funding and supplied the device.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of NeuroEngineering and Rehabilitation (PubMed). Efficacy of a soft robotic exoskeleton for upper-limb rehabilitation in subacute stroke inpatient rehabilitation: a randomised controlled trial.

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Higher ultra-processed food intake was associated with multiple chronic diseases

Cancer-associated coagulopathy stroke carried high early recurrence and mortality risk

A soft robotic glove did not outperform supervised stroke arm training